Ruminating Anthropic: The IPO We Want to Own, and How We Plan to Buy It

Anthropic. You have your own reasons for wanting to own the stock. Here's ours on valuation, how to buy, and when to buy.

ICYMI, the San Francisco company behind Claude filed under the ticker ANT and will start trading THURSDAY MORNING; pricing Wednesday eve, the day after NVDA earnings boost to tech stocks (🤞). 

The amended prospectus it filed shows ~$17B of third-quarter revenue, up from ~$1.4B a year earlier, and Bloomberg Intelligence expects the deal to raise as much as $100 billion, the largest IPO everrr.

This is a business we want to own. The real question isn't whether to get in line. It's when to walk in, and how much to order.

Valuation

Is the price sane? Expectations have already cooled, from ~$2T to ~$1.5T, according to Reuters. Bloomberg Intelligence's Mandeep Singh (whom I respect and adore) lands at $1.6 to $1.8 trillion, or 27 to 30 times forward sales on roughly $58 billion of 2026 revenue, a Palantir-style multiple. NYU's Aswath Damodaran, the dean of valuation, pegs it at $1.475 trillion and says he'll sit it out if it prices well above that.

At $1.5 trillion, ANT trades at about 42 times its last four quarters of revenue. History isn't kind to that zip code; IPOs priced above 40 times sales lost an average of 44.8% over the next three years.

Expensive versus history. Defensible versus its growth. Nowhere near a bargain.

I wouldn’t be surprised if it is bid up to $2.5T month one and you'll eventually own it in an index anyway, so how you invest matters more than whether you invest.

Market Participant

My clients benefit from a hands-on approach to planning and tax advice. But another deliverable I am committed to is being an active market participant; thoughtful, pre-emptive, anticipatory.

Something we want to participate in is what is happening at Anthropic. Their stock has no chart yet, so here's our playbook.

Rule one: participate in the book building with an initial tranche, but don't chase the price higher. Research shows investors who bought IPOs at the first-day close trailed the market by 20.5 percentage points over three years. Cestrian's approach rhymes: start small on day one, then accumulate in sideways, rangebound action.

Rule two: wait for the first base, a sideways range that typically forms in the first month and pulls back less than 20%, then buy the breakout on heavy volume, a setup Investor's Business Daily has tracked foreverrr.

Rule three: respect the calendar. SpaceX set the bar with the most thoughtful lockup sequence we've seen. Mizuho's work on SpaceX found its unlocks were more a volume event than a price event: trading volume rose about 40%, while the average three-day price hit was just 1.5%. Holders don't get clobbered, and buyers get a modest discount.

ANT is following a similar playbook, with 23 separate unlock dates in its first year.

ANT's 23 scheduled unlock dates, from IPO day to the final release. Source: Anthropic amended prospectus. Earnings-linked dates are estimates.

Bloomberg Intelligence found Astera Labs, Reddit and Rubrik each gained 67% to 126% in market value in the 180 days after their lockups expired, while stocks that ripped before the unlock, like CoreWeave, went flat afterward.

Market value before and after lockup expiry for recent tech IPOs. Source: Bloomberg Intelligence.

So we buy in tranches: a small starter at the IPO, more on the first base breakout, more as the early unlocks get absorbed, a bigger add if the first earnings report confirms growth and margins, and the balance after the founders' shares unlock.

Our tranche plan for building an ANT position around the unlock calendar. Illustrative framework, not advice.

Bottom line: we like the business, we respect the price, and we're not chasing the opening-day run-up.

If you hold private Anthropic shares, already carry a lot of AI exposure, or just want to talk through where ANT fits in your plan, reach out. Employees and early investors: talk to a professional (ahem).

Dogpatch has always been a neighborhood that builds things, and we like owning the builders in a thoughtful way.

See you around the 'hood,
Adam

Disclosure: This post is for informational purposes only and is not a recommendation to buy or sell any security. Dogpatch Wealth may hold or acquire shares of Anthropic for clients. IPO allocations are not guaranteed, new issues can be highly volatile, and past performance does not predict future results.

Adam Gould

Adam Gould is the Founder and Wealth Advisor at Dogpatch Wealth in San Francisco. He has twenty years experience in wealth management and launched his independent practice in 2014.

https://dogpatchwealth.com
Next
Next

Buy Nasdaq 100